Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TSPAN9 intronic transcript 1 (TSPAN9-IT1) is a long non-coding RNA transcribed from the intronic region of the TSPAN9 gene and is annotated in the HGNC lncRNA gene set[5]. Like other non-protein coding RNAs, TSPAN9-IT1 is believed to participate in the regulation of gene expression, potentially by interacting with chromatin, RNAs, or proteins[2][6]. Its specific biological roles, disease associations, and drug interactions have not yet been clearly established in the current scientific literature. While other lncRNAs are increasingly recognized as important regulators in various diseases, particularly cancers, TSPAN9-IT1's functional significance remains to be elucidated[5][6].
None known. As there are no drugs targeting TSPAN9-IT1, no mechanisms of action have been described for therapeutics against it.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TSPAN9 intronic transcript 1 (TSPAN9-IT1).